Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
HYDROXYZINE PAMOATE
(1959)
Small molecule
Histamine H1 receptor antagonist
ORAL
Approved
Anxiety; Neurotic Disorders; Pruritus; Skin Diseases; Urticaria
HYDROXYZINE PAMOATE
×
Maximum Phase:
4
First Approval:
1959
UNII:
M20215MUFR
Molecule Type:
Small molecule
Molecular Formula:
C44H43ClN2O8
Molecular Weight:
763.29
AlogP:
3.06
PSA:
35.94
HBD:
1.0
HBA:
#RotB:
8.0
Source:
OXYMORPHONE HYDROCHLORIDE
(1959)
Small molecule
Opioid receptors; mu/kappa/delta agonist
INJECTION; ORAL; RECTAL
Approved
Acute Pain; Pain; Pain, Postoperative
OXYMORPHONE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1959
UNII:
5Y2EI94NBC
Molecule Type:
Small molecule
Molecular Formula:
C17H20ClNO4
Molecular Weight:
337.8
AlogP:
0.75
PSA:
70.0
HBD:
2.0
HBA:
#RotB:
0.0
Source:
ISOCARBOXAZID
(1959)
Small molecule
Monoamine oxidase inhibitor
ORAL
Approved
Depression; Depressive Disorder; Depressive Disorder, Major
ISOCARBOXAZID
×
Maximum Phase:
4
First Approval:
1959
UNII:
34237V843T
Molecule Type:
Small molecule
Molecular Formula:
C12H13N3O2
Molecular Weight:
231.25
AlogP:
1.42
PSA:
67.16
HBD:
2.0
HBA:
#RotB:
4.0
Source:
THIOTEPA
(1959)
Small molecule
DNA inhibitor
INJECTION; INTRAVENOUS
Approved
Adenocarcinoma; Carcinoma; Hodgkin Disease; Neoplasms
THIOTEPA
×
Maximum Phase:
4
First Approval:
1959
UNII:
905Z5W3GKH
Molecule Type:
Small molecule
Molecular Formula:
C6H12N3PS
Molecular Weight:
189.22
AlogP:
0.16
PSA:
9.03
HBD:
0.0
HBA:
#RotB:
3.0
Source:
DEMECARIUM
(1959)
Small molecule
Unknown
Unknown
Approved
Glaucoma
DEMECARIUM
×
Maximum Phase:
4
First Approval:
1959
UNII:
ILP8XJ8R5K
Molecule Type:
Small molecule
Molecular Formula:
C32H52N4O4+2
Molecular Weight:
556.79
AlogP:
6.76
PSA:
59.08
HBD:
0.0
HBA:
#RotB:
15.0
Source:
SULFINPYRAZONE
(1959)
Small molecule
Solute carrier family 22 member 12 inhibitor
ORAL
Approved
Gout
SULFINPYRAZONE
×
Maximum Phase:
4
First Approval:
1959
UNII:
V6OFU47K3W
Molecule Type:
Small molecule
Molecular Formula:
C23H20N2O3S
Molecular Weight:
404.49
AlogP:
3.8
PSA:
57.69
HBD:
0.0
HBA:
#RotB:
6.0
Source:
METHYLPREDNISOLONE SODIUM SUCCINATE
(1959)
Small molecule
Glucocorticoid receptor agonist
INJECTION
Approved
Acne Vulgaris; Anemia; Arthritis, Juvenile; Arthritis, Psoriatic; Arthritis, Rheumatoid; Asthma; Bursitis; Dermatitis; Endocrine System Diseases; Inflammation; Leukemia; Lymphoma; Multiple Sclerosis; Osteoarthritis; Serum Sickness; Uveitis, Posterior
METHYLPREDNISOLONE SODIUM SUCCINATE
×
Maximum Phase:
4
First Approval:
1959
UNII:
LEC9GKY20K
Molecule Type:
Small molecule
Molecular Formula:
C26H33NaO8
Molecular Weight:
496.53
AlogP:
2.22
PSA:
138.2
HBD:
3.0
HBA:
#RotB:
6.0
Source:
NANDROLONE PHENPROPIONATE
(1959)
Small molecule
Androgen Receptor agonist
INJECTION
Approved
Eye Diseases
NANDROLONE PHENPROPIONATE
×
Maximum Phase:
4
First Approval:
1959
UNII:
KF7Z9K2T3W
Molecule Type:
Small molecule
Molecular Formula:
C27H34O3
Molecular Weight:
406.57
AlogP:
5.67
PSA:
43.37
HBD:
0.0
HBA:
#RotB:
4.0
Source:
CHLORAMPHENICOL SUCCINIC ACID
(1959)
Small molecule
Unknown
Unknown
Approved
Unknown
CHLORAMPHENICOL SUCCINIC ACID
×
Maximum Phase:
4
First Approval:
1959
UNII:
ZCX619U9A1
Molecule Type:
Small molecule
Molecular Formula:
C15H16Cl2N2O8
Molecular Weight:
423.2
AlogP:
1.32
PSA:
156.07
HBD:
3.0
HBA:
#RotB:
10.0
Source:
MEDROXYPROGESTERONE ACETATE
(1959)
Small molecule
Progesterone receptor agonist
INJECTION; ORAL; SUBCUTANEOUS
Approved
Carcinoma, Renal Cell; Endometriosis; Hyperplasia; Neoplasms; Uterine Hemorrhage
MEDROXYPROGESTERONE ACETATE
×
Maximum Phase:
4
First Approval:
1959
UNII:
C2QI4IOI2G
Molecule Type:
Small molecule
Molecular Formula:
C24H34O4
Molecular Weight:
386.53
AlogP:
4.66
PSA:
60.44
HBD:
0.0
HBA:
#RotB:
2.0
Source:
DIETHYLPROPION HYDROCHLORIDE
(1959)
Small molecule
Dopamine transporter inhibitor
ORAL
Approved
Obesity
DIETHYLPROPION HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1959
UNII:
19V2PL39NG
Molecule Type:
Small molecule
Molecular Formula:
C13H20ClNO
Molecular Weight:
241.76
AlogP:
2.6
PSA:
20.31
HBD:
0.0
HBA:
#RotB:
5.0
Source:
BENDROFLUMETHIAZIDE
(1959)
Small molecule
Thiazide-sensitive sodium-chloride cotransporter inhibitor
ORAL
Approved
Cardiovascular Diseases; Hypertension
BENDROFLUMETHIAZIDE
×
Maximum Phase:
4
First Approval:
1959
UNII:
5Q52X6ICJI
Molecule Type:
Small molecule
Molecular Formula:
C15H14F3N3O4S2
Molecular Weight:
421.42
AlogP:
1.63
PSA:
118.36
HBD:
3.0
HBA:
#RotB:
3.0
Source:
MEPIVACAINE HYDROCHLORIDE
(1960)
Small molecule
Sodium channel alpha subunit blocker
Unknown
Approved
Unknown
MEPIVACAINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1960
UNII:
4VFX2L7EM5
Molecule Type:
Small molecule
Molecular Formula:
C15H23ClN2O
Molecular Weight:
282.82
AlogP:
2.73
PSA:
32.34
HBD:
1.0
HBA:
#RotB:
2.0
Source:
BENZTHIAZIDE
(1960)
Small molecule
Thiazide-sensitive sodium-chloride cotransporter inhibitor
ORAL
Approved
Unknown
BENZTHIAZIDE
×
Maximum Phase:
4
First Approval:
1960
UNII:
1TD8J48L61
Molecule Type:
Small molecule
Molecular Formula:
C15H14ClN3O4S3
Molecular Weight:
431.95
AlogP:
2.24
PSA:
118.69
HBD:
2.0
HBA:
#RotB:
5.0
Source:
CHLORDIAZEPOXIDE HYDROCHLORIDE
(1960)
Small molecule
GABA-A receptor; anion channel positive allosteric modulator
INJECTION; ORAL
Approved
Unknown
CHLORDIAZEPOXIDE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1960
UNII:
MFM6K1XWDK
Molecule Type:
Small molecule
Molecular Formula:
C16H15Cl2N3O
Molecular Weight:
336.22
AlogP:
2.95
PSA:
50.46
HBD:
1.0
HBA:
#RotB:
1.0
Source:
DEMECLOCYCLINE HYDROCHLORIDE
(1960)
Small molecule
Bacterial 70S ribosome inhibitor
ORAL
Approved
Infections
DEMECLOCYCLINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1960
UNII:
29O079NTYT
Molecule Type:
Small molecule
Molecular Formula:
C21H22Cl2N2O8
Molecular Weight:
501.32
AlogP:
0.26
PSA:
181.62
HBD:
6.0
HBA:
#RotB:
2.0
Source:
CHLORTHALIDONE
(1960)
Small molecule
Thiazide-sensitive sodium-chloride cotransporter inhibitor
ORAL
Approved
Angina Pectoris; Cardiovascular Diseases; Glomerulonephritis; Heart Failure; Hypertension; Kidney Failure, Chronic; Nephrotic Syndrome; Toxemia
CHLORTHALIDONE
×
Maximum Phase:
4
First Approval:
1960
UNII:
Q0MQD1073Q
Molecule Type:
Small molecule
Molecular Formula:
C14H11ClN2O4S
Molecular Weight:
338.77
AlogP:
0.92
PSA:
109.49
HBD:
3.0
HBA:
#RotB:
2.0
Source:
DEMECLOCYCLINE
(1960)
Small molecule
Unknown
Unknown
Approved
Bacterial Infections
DEMECLOCYCLINE
×
Maximum Phase:
4
First Approval:
1960
UNII:
5R5W9ICI6O
Molecule Type:
Small molecule
Molecular Formula:
C21H21ClN2O8
Molecular Weight:
464.86
AlogP:
0.26
PSA:
181.62
HBD:
6.0
HBA:
#RotB:
2.0
Source:
DIPHENOXYLATE HYDROCHLORIDE
(1960)
Small molecule
Mu opioid receptor agonist
Unknown
Approved
Unknown
DIPHENOXYLATE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1960
UNII:
W24OD7YW48
Molecule Type:
Small molecule
Molecular Formula:
C30H33ClN2O2
Molecular Weight:
489.06
AlogP:
5.48
PSA:
53.33
HBD:
0.0
HBA:
#RotB:
8.0
Source:
METHYCLOTHIAZIDE
(1960)
Small molecule
Thiazide-sensitive sodium-chloride cotransporter inhibitor
ORAL
Approved
Cardiovascular Diseases
METHYCLOTHIAZIDE
×
Maximum Phase:
4
First Approval:
1960
UNII:
L3H46UAC61
Molecule Type:
Small molecule
Molecular Formula:
C9H11Cl2N3O4S2
Molecular Weight:
360.24
AlogP:
0.6
PSA:
109.57
HBD:
2.0
HBA:
#RotB:
2.0
Source:
AMPHETAMINE SULFATE
(1960)
Small molecule
Dopamine transporter releasing agent
ORAL
Approved
Attention Deficit Disorder with Hyperactivity; Narcolepsy
AMPHETAMINE SULFATE
×
Maximum Phase:
4
First Approval:
1960
UNII:
6DPV8NK46S
Molecule Type:
Small molecule
Molecular Formula:
C9H15NO4S
Molecular Weight:
233.29
AlogP:
1.58
PSA:
26.02
HBD:
1.0
HBA:
#RotB:
2.0
Source:
ETHOSUXIMIDE
(1960)
Small molecule
Voltage-gated T-type calcium channel blocker
ORAL
Approved
Epilepsy
ETHOSUXIMIDE
×
Maximum Phase:
4
First Approval:
1960
UNII:
5SEH9X1D1D
Molecule Type:
Small molecule
Molecular Formula:
C7H11NO2
Molecular Weight:
141.17
AlogP:
0.45
PSA:
46.17
HBD:
1.0
HBA:
#RotB:
1.0
Source:
MEPIVACAINE
(1960)
Small molecule
Unknown
Unknown
Approved
Unknown
MEPIVACAINE
×
Maximum Phase:
4
First Approval:
1960
UNII:
B6E06QE59J
Molecule Type:
Small molecule
Molecular Formula:
C15H22N2O
Molecular Weight:
246.35
AlogP:
2.73
PSA:
32.34
HBD:
1.0
HBA:
#RotB:
2.0
Source:
LEVONORDEFRIN
(1960)
Small molecule
Adrenergic receptor alpha-2 agonist
Unknown
Approved
Unknown
LEVONORDEFRIN
×
Maximum Phase:
4
First Approval:
1960
UNII:
V008L6478D
Molecule Type:
Small molecule
Molecular Formula:
C9H13NO3
Molecular Weight:
183.21
AlogP:
0.48
PSA:
86.71
HBD:
4.0
HBA:
#RotB:
2.0
Source:
TRICHLORMETHIAZIDE
(1960)
Small molecule
Thiazide-sensitive sodium-chloride cotransporter inhibitor
ORAL
Approved
Cardiovascular Diseases
TRICHLORMETHIAZIDE
×
Maximum Phase:
4
First Approval:
1960
UNII:
Q58C92TUN0
Molecule Type:
Small molecule
Molecular Formula:
C8H8Cl3N3O4S2
Molecular Weight:
380.66
AlogP:
0.82
PSA:
118.36
HBD:
3.0
HBA:
#RotB:
2.0
Source:
CHLORMEZANONE
(1960)
Small molecule
Unknown
ORAL
Approved
Unknown
CHLORMEZANONE
×
Maximum Phase:
4
First Approval:
1960
UNII:
GP568V9G19
Molecule Type:
Small molecule
Molecular Formula:
C11H12ClNO3S
Molecular Weight:
273.74
AlogP:
1.62
PSA:
54.45
HBD:
0.0
HBA:
#RotB:
1.0
Source:
GUANETHIDINE
(1960)
Small molecule
Unknown
Unknown
Approved
Glaucoma; Hypertension
GUANETHIDINE
×
Maximum Phase:
4
First Approval:
1960
UNII:
ZTI6C33Q2Q
Molecule Type:
Small molecule
Molecular Formula:
C10H22N4
Molecular Weight:
198.31
AlogP:
0.53
PSA:
67.64
HBD:
2.0
HBA:
#RotB:
3.0
Source:
PROPIOMAZINE HYDROCHLORIDE
(1960)
Small molecule
Histamine H1 receptor antagonist
INJECTION
Approved
Unknown
PROPIOMAZINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1960
UNII:
70BO17YR03
Molecule Type:
Small molecule
Molecular Formula:
C20H25ClN2OS
Molecular Weight:
376.95
AlogP:
4.83
PSA:
23.55
HBD:
0.0
HBA:
#RotB:
5.0
Source:
NITROFURANTOIN SODIUM
(1960)
Small molecule
DNA inhibitor
INJECTION
Approved
Unknown
NITROFURANTOIN SODIUM
×
Maximum Phase:
4
First Approval:
1960
UNII:
MAL9M0T5LV
Molecule Type:
Small molecule
Molecular Formula:
C8H5N4NaO5
Molecular Weight:
260.14
AlogP:
0.07
PSA:
118.05
HBD:
1.0
HBA:
#RotB:
3.0
Source:
OXYPHENBUTAZONE
(1960)
Small molecule
Cyclooxygenase inhibitor
ORAL
Approved
Arthralgia; Eye Diseases; Myalgia; Rheumatic Diseases
OXYPHENBUTAZONE
×
Maximum Phase:
4
First Approval:
1960
UNII:
H806S4B3NS
Molecule Type:
Small molecule
Molecular Formula:
C19H22N2O4
Molecular Weight:
342.4
AlogP:
3.49
PSA:
60.85
HBD:
1.0
HBA:
#RotB:
5.0
Source:
PROPIOMAZINE
(1960)
Small molecule
Unknown
Unknown
Approved
Unknown
PROPIOMAZINE
×
Maximum Phase:
4
First Approval:
1960
UNII:
242Z0PM79Y
Molecule Type:
Small molecule
Molecular Formula:
C20H24N2OS
Molecular Weight:
340.49
AlogP:
4.83
PSA:
23.55
HBD:
0.0
HBA:
#RotB:
5.0
Source:
METHOHEXITAL SODIUM
(1960)
Small molecule
GABA-A receptor; anion channel positive allosteric modulator
INJECTION
Approved
Unknown
METHOHEXITAL SODIUM
×
Maximum Phase:
4
First Approval:
1960
UNII:
60200PNZ7Q
Molecule Type:
Small molecule
Molecular Formula:
C14H17N2NaO3
Molecular Weight:
284.29
AlogP:
1.31
PSA:
66.48
HBD:
1.0
HBA:
#RotB:
3.0
Source:
METHOHEXITAL
(1960)
Small molecule
Unknown
Unknown
Approved
Unknown
METHOHEXITAL
×
Maximum Phase:
4
First Approval:
1960
UNII:
E5B8ND5IPE
Molecule Type:
Small molecule
Molecular Formula:
C14H18N2O3
Molecular Weight:
262.31
AlogP:
1.31
PSA:
66.48
HBD:
1.0
HBA:
#RotB:
3.0
Source:
ATROPINE
(1960)
Small molecule
Muscarinic acetylcholine receptor M1 antagonist
INTRAMUSCULAR
Approved
Digestive System Diseases; Mydriasis; Poisoning
ATROPINE
×
Maximum Phase:
4
First Approval:
1960
UNII:
7C0697DR9I
Molecule Type:
Small molecule
Molecular Formula:
C17H23NO3
Molecular Weight:
289.37
AlogP:
1.93
PSA:
49.77
HBD:
1.0
HBA:
#RotB:
4.0
Source:
TRIAMCINOLONE ACETONIDE
(1960)
Small molecule
Glucocorticoid receptor agonist
DENTAL; INHALATION; INJECTION; INTRA-ARTICULAR; INTRAMUSCULAR; INTRAVITREAL; NASAL; SUSPENSION; TOPICAL
Approved
Anemia; Arthritis, Gouty; Arthritis, Rheumatoid; Asthma; Bursitis; Dermatitis; Multiple Sclerosis; Mycoses; Nasal Obstruction; Osteoarthritis; Pain; Rhinitis, Allergic, Seasonal; Serum Sickness; Skin Diseases; Tennis Elbow; Tenosynovitis; Tuberculosis, Pulmonary; Wounds and Injuries
TRIAMCINOLONE ACETONIDE
×
Maximum Phase:
4
First Approval:
1960
UNII:
F446C597KA
Molecule Type:
Small molecule
Molecular Formula:
C24H31FO6
Molecular Weight:
434.5
AlogP:
2.42
PSA:
93.06
HBD:
2.0
HBA:
#RotB:
2.0
Source:
ECHOTHIOPHATE
(1960)
Small molecule
Acetylcholinesterase inhibitor
Unknown
Approved
Glaucoma
ECHOTHIOPHATE
×
Maximum Phase:
4
First Approval:
1960
UNII:
0F350BVT6S
Molecule Type:
Small molecule
Molecular Formula:
C9H23NO3PS+
Molecular Weight:
256.33
AlogP:
2.61
PSA:
35.53
HBD:
0.0
HBA:
#RotB:
8.0
Source:
1
2
…
7
8
9
10
11
12
13
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA